ChartMill assigns a Buy % Consensus number of 84% to PRCT. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-18 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-12 | UBS | Initiate | Buy |
| 2025-12-08 | B of A Securities | Downgrade | Buy -> Neutral |
| 2025-12-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-05 | TD Cowen | Maintains | Buy -> Buy |
| 2025-11-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-05 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-10-15 | Truist Securities | Maintains | Buy -> Buy |
| 2025-09-16 | BTIG | Reiterate | Neutral -> Neutral |
| 2025-09-02 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2025-08-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-07 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-07-07 | Oppenheimer | Initiate | Perform |
| 2025-04-25 | B of A Securities | Maintains | Buy -> Buy |
| 2025-04-11 | Truist Securities | Maintains | Buy -> Buy |
| 2025-02-26 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-02-26 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-12-03 | Wells Fargo | Reiterate | Overweight -> Overweight |
| 2024-12-02 | Morgan Stanley | Initiate | Overweight |
| 2024-11-14 | Jefferies | Initiate | Hold |
| 2024-10-30 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-10-08 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-09-16 | TD Cowen | Maintains | Buy -> Buy |
| 2024-09-03 | Truist Securities | Maintains | Buy -> Buy |
| 2024-08-22 | B of A Securities | Maintains | Buy -> Buy |
| 2024-08-02 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-08-02 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-07-16 | Truist Securities | Maintains | Buy -> Buy |
| 2024-05-06 | TD Cowen | Maintains | Buy -> Buy |
19 analysts have analysed PRCT and the average price target is 53.81 USD. This implies a price increase of 66.01% is expected in the next year compared to the current price of 32.41.
The consensus rating for PROCEPT BIOROBOTICS CORP (PRCT) is 84.2105 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering PROCEPT BIOROBOTICS CORP (PRCT) is 19.